Actively Recruiting

Age: 16Years - 17Years
All Genders
ID07228650

ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes

Led by King's College London · Updated on 2025-11-26

500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

K

King's College London

Lead Sponsor

S

South London and Maudsley NHS Foundation Trust

Collaborating Sponsor

AI-Summary

What this Trial Is About

Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental condition affecting about 5.9% of young people, with late adolescence being a particularly challenging time. This period involves major life changes and a transition from child to adult mental health services, where many young people with ADHD do not successfully transfer, leading to a lack of appropriate support. This research aims to use remote measurement technology to better understand changes during this transition, identify predictors of outcomes, and develop ways to prevent negative effects and support healthy lifestyles for young people with ADHD. The study will remotely monitor 250 young people aged 16 to 17 with a diagnosis of ADHD over two years using the ADHD Remote Technology (ART) assessment and monitoring system. ART includes active monitoring through questionnaires and passive monitoring such as sleep tracking via a smartphone app linked to the RADAR-base mobile health platform. Throughout the study period, participants will use either their own compatible Android phone or a provided study phone and wear a wearable device for continuous data collection. The study team will work with young people to co-design a prototype smartphone app to support ADHD transition, focusing on empowering participants to manage their condition collaboratively with clinicians. Participants will complete self-reported assessments via smartphone regularly, including measures of ADHD symptoms, anxiety, depression, aggression, irritability, nicotine dependence, alcohol use, eating disorders, self-esteem, social support, and engagement with work or studies. Cognitive measures and digital signals related to healthy lifestyle behaviors will also be collected. These assessments occur at baseline and at various intervals up to 24 months. The study emphasizes remote participation and uses continuous monitoring to gather comprehensive data on how symptoms and functioning change during this critical transition period.

CONDITIONS

Brief Title

ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes

Who Can Participate

Age: 16Years - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of DSM-5 ADHD
  • Aged 16 to 17 years
  • Able to give informed consent for participation
  • Willing and able to complete self-reported assessments via smartphone
  • Willing to use either their own compatible Android phone or a study Android phone as their only smartphone during the data collection period
  • Willing to wear the wearable device during the data collection period
  • Parent or guardian of the individual with ADHD, aged 18 or over, willing and able to complete web-based questionnaires
Not Eligible

You will not qualify if you...

  • Psychosis, current major depressive episode, mania, drug dependence in the last six months, or major neurological disorder
  • Recent contact with psychiatric acute care (admission, crisis team, or liaison team in A&E) in the last six months
  • Any major medical disease impacting daily activities, such as hospitalizations
  • Pregnancy
  • IQ less than 70

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Monitoring

Duration - Up to 24 months

Participants complete self-reported assessments via smartphone and wear a wearable device to continuously collect data related to ADHD symptoms, functional impairment, anxiety, depression, aggression, irritability, substance use, lifestyle behaviors, and cognitive measures.

Baseline and repeated assessments every day or every 4 weeks, with some measures every 6 months

Trial Site Locations

Total: 1 location

1

King's College London

London, United Kingdom

Actively Recruiting

Loading map...

Research Team

A

Aislinn Bowler, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Assessing Real Life Effectiveness of Treatment in Neurodevel...

Emotional Dysregulation

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here